Author

E. Su

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:chromatin & epigenetic regulation· 2 Assay:proteomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

M. Hirst· 3 shared L.-A. Fournier· 2 shared M. Moksa· 2 shared P. C. Stirling· 2 shared T. Smith· 2 shared A. Banito· 1 shared A. Carles· 1 shared A. Cheng· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

M. Hirst

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Synovial Sarcoma Chromatin Dynamics Reveal a Continuum in SS18:SSX Reprograming

J. Hofvander, A. Qiu, K. Lee, M. Bilenky, A. Carles, Q. Cao, M. Moksa, J. Steif, E. Su, A. Sotiriou, A. Goytain, L. Hill, S. Singer, I. Andulis, J. Wunder, , M. Hirst

This study examines the epigenomic states of synovial sarcoma using multi-omics analysis, revealing a continuum of epigenomic states and identifying H3K4me3 inhibition as a potential therapeutic strategy.

bioRxiv · May 14, 2024 · PreprintCancer Biology

Genome-wide CRISPR screen identifies KEAP1 perturbation as a vulnerability of ARID1A-deficient cells

L.-A. Fournier, F. Kalantari, J. P. Wells, J. S. Lee, G. Trigo-Gonzalez, M. M. Moksa, T. Smith, J. White, A. Shanks, L. Wang, E. Su, Y. Wang, D. G. Huntsman, M. Hirst, P. C. Stirling

The paper identifies KEAP1 as a genetic dependency in ARID1A-deficient clear cell ovarian carcinoma cells through a genome-wide CRISPR screen, showing KEAP1 perturbation leads to growth inhibition.

bioRxiv · Nov 14, 2023Cancer Biology

Expression and functional evaluation of recombinant human ABO blood group antigen cleaving glycoside hydrolases α-N-acetylgalactosaminidase, α-galactosidase, and endo-β-galactosidase produced in Escherichia coli

W. H. Toh, Y. Kuo, S. K. Hsu, B. Chen, A. J. Lee, E. Liaw, J. Lee, A. Cheng, L. Hwa, K. Hu, S. Chien, C. Wong, K. Chang, M. Hang, S. Hong, , J. Hsu

This study evaluates recombinant glycoside hydrolases for converting A, B, and AB blood types to O by cleaving surface antigens, showing partial success in porcine red blood cells.

bioRxiv · May 4, 2022 · PreprintBiochemistry

Global prediction of candidate R-loop binding and R-loop regulatory proteins

L.-A. Fournier, A. Kumar, T. Smith, E. Su, M. Moksa, M. Hirst, P. C. Stirling

The paper develops a random forest classifier to predict R-loop binding proteins using proteomic features and amino acid composition, and validates new R-loop modulating proteins through CRISPR screening.

bioRxiv · Aug 9, 2021 · PreprintCell Biology